Authors
Latest:
Managing Sustainable Drug Spend: 5 Trends Reshaping Pharmacy Benefits in 2025The US health care market faces transformative changes in 2025, as biosimilars, GLP-1s, and new pharmacy economics reshape how benefit managers balance innovation with affordability.
Latest:
Precision Oncology in Focus: ctDNA's Role in Colon Cancer ManagementSasha Watson, PharmD, BCOP, discusses the emerging role of circulating tumor DNA (ctDNA) in colon cancer, highlighting its potential to enhance precision oncology by improving early detection, guiding adjuvant therapy decisions, and monitoring disease recurrence and treatment resistance.
Latest:
Integrated Outpatient Specialty Neurology Pharmacists Influence Care in Non-MS Clinical SettingsIntegrated health system specialty pharmacies can improve patient care for non–multiple sclerosis neurologic conditions.
Latest:
Interaction Considerations for Common OTC Drug ClassesAlthough OTC medications are generally considered safe when used as directed, there are some key drug interactions for pharmacists to keep in mind when helping patients choose an OTC product.
Latest:
Pharmacists Have a Significant Role in the Prevention of Travel-Related DiseasesWhen helping individuals prepare for travel, pharmacists must make travel health recommendations and know common travel-related immunizations and additional resources.
Latest:
AHA Statement Reviews Benefits, Risks of Alternative Therapies for Heart FailureThe AHA acknowledged that complementary and alternative medicines are widely used by heart failure patients but warned that there is limited scientific evidence to support their efficacy.
Latest:
Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWDThis abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Latest:
Balancing Pharmaceutical Reimbursement and Market Access With the Right PartnerManufacturers must find the right balance in drug pricing, so that medications are appealing to both public and private insurers while still remaining profitable throughout their lifecycle.
Latest:
Case Study: New Treatment Options for Patients With Chronic Lymphocytic LeukemiaWith a better understanding of the underlying pathophysiology of chronic lymphocytic leukemia and the introduction of novel targeted agents, such as Bruton kinase Inhibitors, the prognosis of high-risk patients has changed dramatically.
Latest:
Vax-Innovation: Incorporating the Newly Approved RSV and Pneumococcal Vaccines Into Community Pharmacy WorkflowBest practices to train staff and team members to engage patients and to ease the new vaccine offerings into the workflow are also discussed.
Latest:
St. John’s Wort Could Show Benefit in Major Depressive DisorderPatients with MDD may also seek complementary or alternative therapies in the form of dietary supplements which might be perceived by patients to be natural and safer than medicinal agents.
Latest:
Comparative Oncology: Advances in Cancer Care from Pets to HumansDogs share a number of cancers with humans, including melanoma, non-Hodgkin lymphoma, leukemia, and osteosarcoma.
Latest:
Understand Effective Strategies for Monitoring Topical Dermatological AgentsMatthew Zirwas, MD, highlights the discrepancy between perceived and actual usage, citing studies that reveal patients often overestimate their compliance.
Latest:
Pharmacy’s Role in Treating Rare Disease: Connecting Patients, Providers, Payers, and PharmaPharmacy's position at the intersection of the care team gives it a unique ability to connect providers, payers, and pharmaceutical manufacturers, and support patients to maximize their health outcomes.
Latest:
The Blood Detective: Tackling Medication-Induced Hematological DisordersThese disorders can be fatal, making pharmacists’ role in detection crucial.
Latest:
Advances in the Management of HR+/HER2– Ultralow and -Low Metastatic Breast Cancer: New Horizons and Treatment FrontiersAntibody-drug conjugates have revolutionized metastatic breast cancer treatment and classification.
Latest:
Metal Ion Chelators Hold Enormous Potential in Neurodegenerative DisordersMonitoring metal ion concentrations and chelation therapy is hypothesized to alleviate symptoms and diseases caused by neuroinflammation.
Latest:
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists AlikeGustavo Alva, MD, a board-certified psychiatrist, discusses the importance of mental health awareness among pharmacists and patients.
Latest:
Pharmacy Students Lead Drive-Through Influenza Vaccination EventIdaho State University partners with the Idaho Immunization Coalition to effectively and safely vaccinate patients against influenza.
Latest:
Impact of PD-1 and PD-L1 Expression on Overall Survival in Patients With NSCLC and MelanomaPharmacists play a vital role in therapy selection.
Latest:
Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing SarcomaThis retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.
Latest:
Your Company Receives a Subpoena – What Now?With the growth of civil and criminal litigation, more companies in the health care space are receiving subpoenas commanding them to provide information to a third party.
Latest:
ASCO 2025: Stratifying NSCLC Treatment by HER2-Alteration SubtypeNikita Dahake, MD; Hossein Borghaei, DO, MS; and Yasmine Baca, MS, PhD candidate, MB(ASCP)CM, explore how distinct HER2-alteration subtypes in non-small cell lung cancer (NSCLC) impact survival outcomes, co-mutation profiles, and treatment response to immunotherapy-based regimens.
Latest:
Pharmacy Care Coaches Improve Outcomes in Patients With DiabetesCare Coach program offers a comprehensive set of pharmacy and counseling services to patients struggling to manage their diabetes.
Latest:
Combat Methamphetamine Epidemic Act of 2005 Takes Aim at Drug CrisisCurtailing the availability of meth precursors in the principal focus of the law, paving the way for states to follow suit.
Latest:
The Impact of COVID-19 on Cervical, Breast Cancer ScreeningsBreast cancer screening guidelines using mammography vary among guiding bodies, including the American Cancer Society and the American Academy of Family Physicians.
Latest:
New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell LymphomaThe FDA approved acalabrutinib as a frontline option for untreated mantle cell lymphoma.
Latest:
How to Use Data to Transform Pharmacy PracticeTips to help community-based pharmacists use the data at their fingertips to better market and provide the enhanced pharmacy services that drive practice transformation.
Latest:
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular CareFrank Qian, MD, MPH, discusses the integration of omega-3 fatty acid therapy alongside statins and PCSK9 inhibitors in cardiovascular risk management, highlighting the distinct mechanisms of benefit and lack of significant drug interactions.
